Chronic Therapy

JM Financial raised concerns around Mankind Pharma's recent BSV acquisition, which was executed at a high valuation and is expected to dilute return on capital

Chronic therapies and price increases drove 7.8 per cent growth in India's pharma market in April 2025, with cardiac and gastrointestinal segments showing double-digit value gains

But a fall in doctor visits hit acute therapy drugs. July saw a major turnaround

Top pharma companies will continue to face severe pricing pressure and regulatory overhang in FY18